A detailed history of Evernest Financial Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Evernest Financial Advisors, LLC holds 7,581 shares of JNJ stock, worth $1.18 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
7,581
Previous 7,832 3.2%
Holding current value
$1.18 Million
Previous $1.14 Million 7.34%
% of portfolio
0.34%
Previous 0.52%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$145.48 - $167.38 $36,515 - $42,012
-251 Reduced 3.2%
7,581 $1.23 Million
Q2 2024

Aug 07, 2024

SELL
$144.38 - $157.78 $131,818 - $144,053
-913 Reduced 10.44%
7,832 $1.14 Million
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $14,590 - $15,297
-94 Reduced 1.06%
8,745 $1.29 Billion
Q4 2023

May 10, 2024

BUY
$145.6 - $158.88 $172,244 - $187,955
1,183 Added 13.53%
9,928 $1.56 Billion
Q4 2021

Feb 13, 2024

BUY
$155.93 - $173.01 $1.38 Million - $1.53 Million
8,839 New
8,839 $1.39 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Evernest Financial Advisors, LLC Portfolio

Follow Evernest Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evernest Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evernest Financial Advisors, LLC with notifications on news.